Page last updated: 2024-09-03

2-(n,n-dipropyl)amino-5,6-dihydroxytetralin and Disease Models, Animal

2-(n,n-dipropyl)amino-5,6-dihydroxytetralin has been researched along with Disease Models, Animal in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dijkstra, D; Johnson, SJ; Meltzer, LT; Venhuis, BJ; Wikström, HV; Wise, LD; Wustrow, D1

Other Studies

1 other study(ies) available for 2-(n,n-dipropyl)amino-5,6-dihydroxytetralin and Disease Models, Animal

ArticleYear
Orally active oxime derivatives of the dopaminergic prodrug 6-(N,N-di-n-propylamino)-3,4,5,6,7,8-hexahydro-2H-naphthalen-1-one. Synthesis and pharmacological activity.
    Journal of medicinal chemistry, 2003, Sep-11, Volume: 46, Issue:19

    Topics: Administration, Oral; Animals; Antiparkinson Agents; Cell Line; CHO Cells; Cricetinae; Disease Models, Animal; Dopamine Agents; Medial Forebrain Bundle; Motor Activity; Naphthalenes; Neurons; Oxidopamine; Oximes; Parkinson Disease; Prodrugs; Rats; Receptors, Dopamine D1; Receptors, Dopamine D2; Recombinant Proteins; Stereoisomerism; Transfection

2003